Arcturus Therapeutics Ltd (ARCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -50,749 | -26,964 | -65,783 | -36,704 | -23,256 |
| Depreciation Amortization | 1,301 | 658 | 3,025 | 2,343 | 1,580 |
| Accounts receivable | 3,751 | 4,221 | -1,590 | -3,977 | -13,230 |
| Accounts payable and accrued liabilities | 179 | -142 | -2,959 | -1,616 | 3,429 |
| Other Working Capital | 1,513 | 2,573 | -39,200 | -42,593 | -32,228 |
| Other Operating Activity | 4,654 | 213 | 32,236 | 24,503 | 22,812 |
| Operating Cash Flow | $-39,351 | $-19,441 | $-74,271 | $-58,044 | $-40,893 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 52 | 34 | -230 | -318 | -137 |
| Investing Cash Flow | $52 | $34 | $-230 | $-318 | $-137 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 15,000 | 15,000 | 15,000 |
| Debt Repayment | N/A | N/A | N/A | -15,000 | -15,000 |
| Common Stock Issued | 16 | 16 | 13,382 | 1,694 | 469 |
| Other Financing Activity | 0 | 0 | -15,000 | 0 | 0 |
| Financing Cash Flow | $16 | $16 | $13,382 | $1,694 | $469 |
| Beginning Cash Position | 232,794 | 232,794 | 293,913 | 293,913 | 293,913 |
| End Cash Position | 193,511 | 213,403 | 232,794 | 237,245 | 253,352 |
| Net Cash Flow | $-39,283 | $-19,391 | $-61,119 | $-56,668 | $-40,561 |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,351 | -19,441 | -74,271 | -58,044 | -40,893 |
| Capital Expenditure | N/A | N/A | -230 | -318 | -137 |
| Free Cash Flow | -39,351 | -19,441 | -74,501 | -58,362 | -41,030 |